Basso Capital Management’s Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock VHAQ.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-857,180
Closed -$103K 223
2022
Q3
$103K Hold
857,180
0.02% 208
2022
Q2
$69K Hold
857,180
0.01% 432
2022
Q1
$103K Hold
857,180
0.01% 446
2021
Q4
$158K Hold
857,180
0.02% 352
2021
Q3
$180K Buy
857,180
+86,928
+11% +$19.2K 0.02% 313
2021
Q2
$208K Hold
770,252
0.03% 316
2021
Q1
$139K Buy
+770,252
New +$180K 0.02% 255

Other funds holding VHAQ.RT

Basso Capital Management's VHAQ.RT Position: Q4 2022 in Review

Basso Capital Management sold out of Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock (VHAQ.RT) in Q4 2022, closing a stake of 857,180 shares — an estimated $103K sold.

Basso Capital Management first reported a position in VHAQ.RT in Q1 2021 and held it in 7 quarters. The position peaked at $208K in Q2 2021. 27 funds tracked by Wall St. Rank hold VHAQ.RT as of Q4 2022.

  • Basso Capital Management reported no remaining Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position as of Q4 2022 after selling out during the quarter.
  • Basso Capital Management sold 857,180 Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock shares in Q4 2022, an estimated $103K.
  • Basso Capital Management first reported a position in Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock in Q1 2021 and held it in 7 quarters.
  • Basso Capital Management's Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position peaked at $208K in Q2 2021.
  • 27 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock as of Q4 2022.

Based on Basso Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.